A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers. [electronic resource]
Producer: 20111212Description: 2304-9 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Carcinoma, Squamous Cell -- drug therapy
- Combined Modality Therapy
- Disease Progression
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Hydroxyurea -- administration & dosage
- Male
- Middle Aged
- Neoplasm Staging
- Radiotherapy Dosage
- Squamous Cell Carcinoma of Head and Neck
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.